780 Shares in Danaher Co. (NYSE:DHR) Purchased by Kanawha Capital Management LLC

Kanawha Capital Management LLC acquired a new position in shares of Danaher Co. (NYSE:DHR) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 780 shares of the conglomerate’s stock, valued at approximately $217,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. BSW Wealth Partners raised its holdings in shares of Danaher by 10.3% in the 3rd quarter. BSW Wealth Partners now owns 3,579 shares of the conglomerate’s stock worth $995,000 after purchasing an additional 334 shares during the period. Nvwm LLC increased its position in Danaher by 3.9% in the third quarter. Nvwm LLC now owns 5,503 shares of the conglomerate’s stock worth $1,530,000 after buying an additional 209 shares during the last quarter. Fort Pitt Capital Group LLC raised its stake in shares of Danaher by 3.2% in the third quarter. Fort Pitt Capital Group LLC now owns 238,092 shares of the conglomerate’s stock valued at $66,194,000 after buying an additional 7,421 shares during the period. Pure Financial Advisors LLC purchased a new position in shares of Danaher during the 3rd quarter valued at $202,000. Finally, Conning Inc. grew its stake in shares of Danaher by 1.8% during the 3rd quarter. Conning Inc. now owns 21,259 shares of the conglomerate’s stock worth $5,910,000 after acquiring an additional 366 shares during the period. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

DHR has been the topic of several recent research reports. Leerink Partners upped their price objective on shares of Danaher from $275.00 to $280.00 and gave the company an “outperform” rating in a report on Wednesday, July 24th. Barclays cut their price objective on shares of Danaher from $285.00 to $275.00 and set an “equal weight” rating for the company in a report on Wednesday, October 23rd. Stephens reissued an “overweight” rating and set a $315.00 target price on shares of Danaher in a report on Wednesday, October 23rd. Wolfe Research raised Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price target for the company in a report on Thursday, October 31st. Finally, TD Cowen boosted their price objective on Danaher from $310.00 to $315.00 and gave the company a “buy” rating in a research note on Wednesday, October 23rd. Six investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $287.16.

Insiders Place Their Bets

In other news, SVP Georgeann Couchara sold 952 shares of Danaher stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $268.37, for a total value of $255,488.24. Following the transaction, the senior vice president now owns 4,212 shares of the company’s stock, valued at $1,130,374.44. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 11.10% of the stock is currently owned by corporate insiders.

Danaher Price Performance

NYSE:DHR opened at $247.18 on Tuesday. The firm has a market capitalization of $178.53 billion, a price-to-earnings ratio of 47.17, a PEG ratio of 4.51 and a beta of 0.85. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01. The business has a 50 day simple moving average of $266.53 and a 200-day simple moving average of $260.74. Danaher Co. has a 1 year low of $192.35 and a 1 year high of $281.70.

Danaher (NYSE:DHR) last issued its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.57 by $0.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The firm had revenue of $5.80 billion during the quarter, compared to analyst estimates of $5.59 billion. During the same period in the previous year, the firm earned $2.02 earnings per share. The business’s revenue was up 3.1% on a year-over-year basis. Equities analysts forecast that Danaher Co. will post 7.51 EPS for the current year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were issued a $0.27 dividend. The ex-dividend date was Friday, September 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.44%. Danaher’s dividend payout ratio is presently 20.61%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.